Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 16, 2026 16:15 ET | Source: Zenas BioPharma

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...
January 16, 2026 16:15 ET | Source: Turbo Energy S.A.

Turbo Energy Receives Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement

VALENCIA, Spain, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Turbo Energy S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global provider of AI-optimized solar energy storage technologies and...
January 16, 2026 16:10 ET | Source: First Western Financial, Inc.

First Western Trust Expands Arts Investment with Landmark Digital Installation in Boulder

DENVER, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Since its founding in 2004, First Western Trust has remained deeply committed to building strong, vibrant communities through philanthropy, economic...
January 16, 2026 16:05 ET | Source: The Hain Celestial Group, Inc.

Hain Celestial Announces Fiscal 2026 Second Quarter Earnings Results Conference Call and Webcast

HOBOKEN, N.J., Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through...
January 16, 2026 16:05 ET | Source: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery,...
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc.

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific...
January 16, 2026 16:05 ET | Source: Arteris, Inc.

Arteris Announces New Employment Inducement Grants

Arteris announces new employment inducement grants
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of...
January 16, 2026 16:01 ET | Source: Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

SOUTH SAN FRANCISCO, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced that it will host a conference call...
January 16, 2026 16:01 ET | Source: Hingham Institution for Savings

Hingham Savings Reports 2025 Results

HINGHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31,...